SERINE/GLYCINE METABOLISM REPRESENTS A NOVEL TARGETABLE THERAPEUTIC VULNERABILITY IN MYC-AMPLIFIED MEDULLOBLASTOMA

被引：0
|
作者：
Adiamah, Magretta [1 ,2 ]
Poole, Bethany [1 ]
Lindsey, Janet C. [1 ]
Swartz, Shanel [1 ]
Morcavallo, Alaide [3 ,4 ]
Gosling, Samantha Jepson [1 ]
Singh, Mankaran [1 ]
Blair, Helen J. [1 ]
Kohe, Sarah [5 ]
Zhang, Tong [6 ]
Maddocks, Oliver [6 ]
Peet, Andrew [5 ]
Chesler, Louis [3 ,4 ]
Hickson, Ian [1 ]
Maxwell, Ross [1 ]
Hill, Rebecca M. [1 ]
Clifford, Steven C. [1 ]
机构：
[1] Newcastle Univ, Ctr Canc, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[2] Luxembourg Inst Hlth, Dept Canc Res, Luxembourg, Luxembourg
[3] Inst Canc Res ICR, Div Clin Studies, London, England
[4] Royal Marsden NHS Trust, Sutton, Surrey, England
[5] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England
[6] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDB-74
引用
收藏
页数：1
相关论文
共 50 条
  • [31] OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma
    Lu, Yining
    Labak, Collin M.
    Jain, Neha
    Purvis, Ian J.
    Guda, Maheedhara R.
    Bach, Sarah E.
    Tsung, Andrew J.
    Asuthkar, Swapna
    Velpula, Kiran K.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (03): : 647 - 656
  • [32] Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability
    Xie, Jingwu
    Nguyen, Chi Mai
    Turk, Anita
    Nan, Hongmei
    Imperiale, Thomas F.
    House, Michael
    Huang, Kun
    Su, Jing
    GENES & DISEASES, 2023, 10 (04) : 1172 - 1174
  • [33] IDENTIFICATION OF NOVEL EPIGENETIC DRUG COMBINATIONS WITH SYNERGISTIC INHIBITORY EFFECTS AGAINST MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
    Zhang, Lei
    Li, Meng
    Sui, Yi
    Liu, Fang
    Jiang, Wenyan
    Li, Tiantian
    Tang, Yujie
    NEURO-ONCOLOGY, 2017, 19 : 193 - 193
  • [34] Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
    Coulter, Don W.
    Chhonker, Yashpal S.
    Kumar, Devendra
    Kesherwani, Varun
    Aldhafiri, Wafaa N.
    McIntyre, Erin M.
    Alexander, Gracey
    Ray, Sutapa
    Joshi, Shantaram S.
    Li, Rongshi
    Murry, Daryl J.
    Chaturvedi, Nagendra K.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [35] Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
    Don W. Coulter
    Yashpal S. Chhonker
    Devendra Kumar
    Varun Kesherwani
    Wafaa N. Aldhafiri
    Erin M. McIntyre
    Gracey Alexander
    Sutapa Ray
    Shantaram S. Joshi
    Rongshi Li
    Daryl J. Murry
    Nagendra K. Chaturvedi
    Journal of Experimental & Clinical Cancer Research, 43
  • [36] Synergistic interaction of HDACi and PLK1i in Group 3 MYC-amplified medulloblastoma
    Valinciute, Gintvile
    Ecker, Jonas
    Hielscher, Thomas
    Schmidt, Christin
    Remke, Marc
    Sigismondo, Gianluca
    Krijgsveld, Jeroen
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    CANCER RESEARCH, 2020, 80 (14) : 71 - 72
  • [37] In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma
    Chen, Tong
    Chen, Huiyao
    Xia, Mingyang
    Liao, Yunfei
    Li, Hao
    Dong, Xinran
    Lin, Yifeng
    Zhou, Wenhao
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [38] CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
    Valinciute, Gintvile
    Ecker, Jonas
    Selt, Florian
    Hielscher, Thomas
    Schmidt, Christin
    Sigaud, Romain
    Ridinger, Johannes
    Gatzweiler, Charlotte
    Picard, Daniel
    Oppermann, Sina
    Blattner-Johnson, Mirjam
    Jones, David T. W.
    Oehme, Ina
    Kool, Marcel
    Remke, Marc
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    NEURO-ONCOLOGY, 2021, 23 : 5 - 5
  • [39] FUNCTIONAL GENOMIC ANALYSIS OF MYC-AMPLIFIED MEDULLOBLASTOMA NOMINATES THE TGFB PATHWAY AS A CLINICALLY VIABLE TARGET
    Henderson, Jacob
    Cho, Hyeyoung
    Davare, Monika
    Tsherniak, Aviad
    Cowley, Glenn
    Weir, Barbara
    Hahn, William C.
    Cho, Yoon-Jae
    NEURO-ONCOLOGY, 2017, 19 : 197 - 197
  • [40] HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-KB PATHWAYS
    Marquardt, Viktoria
    Theruvath, Johanna
    Pauck, David
    Picard, Daniel
    Reifenberger, Guido
    Borkhardt, Arndt
    Cheshier, Samuel
    Kurz, Thomas
    Remke, Marc
    Mitra, Siddhartha
    NEURO-ONCOLOGY, 2020, 22 : 364 - 364
12345